Healthcare / Health Information ServicesNasdaqCM
$2.03
+0.08 (+4.10%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-88.2M · quality 63.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
28/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$204M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-15.6%
↓Gross Margin
47.8%
↓Debt/Equity
0.19
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+6.6%
FCF CAGR
—
FCF margin
-19.8%
FCF / Net income
1.25x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.52B · net income $-242.3M · FCF $-302.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.52B | $1.52B | $1.47B | $1.50B | $1.26B |
| Net Income | $-242.3M | $-242.3M | $-589.5M | $21.3M | $-65.6M |
| EBITDA | $-209.3M | $-209.3M | $-38.6M | $-15.0M | $-55.7M |
| EPS | — | — | -5.72 | 0.21 | -0.61 |
| Gross Margin | 47.8% | 47.8% | 61.3% | 63.7% | 68.7% |
| Operating Margin | -17.5% | -17.5% | -5.8% | -4.1% | -8.2% |
| Net Margin | -15.9% | -15.9% | -40.2% | 1.4% | -5.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.19 | 0.19 | 0.13 | 0.06 | 0.03 |
| Current Ratio | 1.73 | 1.73 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-302.0M | $-302.0M | $-88.2M | $-28.7M | $-128.6M |
| Returns | |||||
| ROE | -15.6% | -15.6% | -32.1% | 0.9% | -2.6% |
| Valuation | |||||
| P/E | — | — | — | 5.44 | — |
| P/B | 0.10 | 0.10 | 0.05 | 0.05 | 0.08 |
| Growth & Yield | |||||
| Revenue Growth | 3.9% | 3.9% | -2.1% | 19.1% | — |
| EPS Growth | — | — | -2851.9% | 134.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+136.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-5.72 → n/d
Residual
+136.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.